- Investing Ideas
- Indian Pharmaceuticals & Biotech High ROE Growth Engines
Indian Pharmaceuticals & Biotech High ROE Growth Engines
Results
9
9 companies
Abbott India
Market Cap: ₹572.3b
Operates as a pharmaceutical company in India.
500488
₹26,933.65
7D
-2.2%
1Y
-17.5%
Ajanta Pharma
Market Cap: ₹464.5b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,718.20
7D
6.0%
1Y
38.2%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹457.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,699.80
7D
3.8%
1Y
-3.2%
Neuland Laboratories
Market Cap: ₹303.7b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,672.45
7D
6.7%
1Y
74.9%
CORONA Remedies
Market Cap: ₹129.2b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,113.10
7D
1.5%
1Y
n/a
Shukra Pharmaceuticals
Market Cap: ₹18.2b
Manufactures and markets pharmaceutical products in India and internationally.
524632
₹41.51
7D
3.6%
1Y
120.3%
Sat Kartar Life
Market Cap: ₹1.9b
An ayurvedic healthcare company, provides ayurvedic products in India.
SATKARTAR
₹122.00
7D
-1.5%
1Y
-29.9%
Aanjaay Industries
Market Cap: ₹574.4m
Does not have significant operations.
524322
₹24.23
7D
1.1%
1Y
22.4%
Colinz Laboratories
Market Cap: ₹203.3m
Manufactures, markets, and trades in pharmaceutical formulations in India.
531210
₹80.72
7D
1.3%
1Y
87.4%